Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Elevance Health Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash and cash equivalents
Fixed maturity securities
Equity securities
Premium receivables, net
Self-funded receivables, net
Other receivables
Other current assets
Assets held for sale
Current assets
Fixed maturity securities
Other invested assets
Long-term investments
Property and equipment, net
Goodwill
Other intangible assets
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


Total assets exhibit a consistent upward trajectory, increasing from 95,683 million USD in March 2021 to 125,827 million USD by March 2026. This growth is distributed across both current and noncurrent asset categories, reflecting a broad expansion of the balance sheet. The expansion is characterized by steady growth in operational receivables and a strategic increase in long-term investment holdings.

Liquidity and Current Asset Composition
Current assets grew from 54,495 million USD to 67,032 million USD over the period. A primary driver of this growth was the significant increase in premium receivables, which rose from 6,111 million USD to 11,525 million USD. Cash and cash equivalents demonstrated periodic volatility, reaching a peak of 10,919 million USD in September 2023 before stabilizing between 7,500 million USD and 9,657 million USD in the final quarters. Fixed maturity securities remained a substantial component of current assets, generally fluctuating between 24,000 million USD and 29,000 million USD.
Investment Strategy and Portfolio Shifts
A notable shift is observed in the investment portfolio. Equity securities experienced a sharp decline from 3,630 million USD in March 2021 to a low of 165 million USD in September 2023, followed by a recovery to 1,511 million USD by March 2026. Conversely, long-term investments and other invested assets showed sustained growth. Long-term investments increased from 5,032 million USD to 12,123 million USD, while other invested assets more than doubled from 4,474 million USD to 11,009 million USD.
Noncurrent Assets and Intangible Value
Noncurrent assets expanded from 41,188 million USD to 58,795 million USD. This growth was heavily influenced by an increase in goodwill, which rose from 21,708 million USD to 28,340 million USD, with a significant step-up occurring between September 2024 and December 2024. Other intangible assets also saw a net increase, moving from 9,352 million USD to 11,093 million USD, suggesting periodic capital allocations toward acquisitions or intangible asset procurement.
Operational Asset Growth
Operational receivables showed a synchronized upward trend. Self-funded receivables increased from 3,109 million USD to 5,098 million USD, and other receivables grew from 3,071 million USD to 6,167 million USD. This suggests a growth in the scale of operations and an increase in the volume of outstanding claims or payments due from third parties.

Assets: Selected Items


Current Assets: Selected Items